Flow-injection ion mobility MS enables rapid multi-omics profiling of bacterial pathogens. It matches LC-IM-MS performance, cuts analysis time from 17 to 2 min.

A UHPLC-MS/MS assay using surrogate calibration and DMIS derivatization quantifies endogenous steroids and contraceptives in plasma with pg/mL sensitivity and regulatory-aligned validation.

A novel ion-repulsion strategy allows rapid ICPMS/MS detection of hydrophobic sulfonylureas with minimal organic solvent, achieving high sensitivity and bypassing the need for organic ICPMS mode.

A new dried plasma microsampling device enables home sampling with high precision and stability, correlating strongly (R > 0.99) with conventional plasma in targeted proteomic analysis.

A rapid, green LC-QqQ-MS/MS method quantifies N-MOX and DNPP in moxifloxacin tablets and eye drops. Validated per ICH, it ensures safety by detecting trace NDSRIs with minimal environmental impact.

Novel LC-MS/MS and UPLC methods quantify NDSRI in mefenamic acid tablets and suspensions with high sensitivity, accuracy, and eco-friendly evaluation via multiple green metrics.

MALDI-MSI on SELECT SERIES MALDI-MRT was optimized for fingerprint imaging. The method improves resolution and enables detection of drugs like antipsychotics in latent prints.

This study aims to develop and validate a rapid IC-ICP-MS method for identifying and quantifying polyphosphonates and their transformation products under environmental conditions.

The study examines treated wastewater from Arctic cruise ships to identify pharmaceuticals and other contaminants, highlighting potential risks to sensitive polar marine environments.

This study evaluates the risk of NDMA formation from macrolide antibiotics, highlighting solubility-related analytical challenges and the role of drug form and storage in NDMA levels.